In the largest WGS study for breast cancer (BRCA-EU from The ICGC Breast Cancer Project), the mutation frequency of MAST2 was 1/569 (0.18%) [37], which was significantly lower than our IBC cohort (Fisher’s test, Bonferroni adjusted p = 0.024). Here, MAST2 is linked to breast carcinoma.